Cargando…

Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes

Objectives: Diabetic kidney disease (DKD) is an independent predictor of cardiovascular morbidity and mortality in type 1 diabetes (T1D). We aimed to explore clinical and biochemical factors, including the achievement of American Diabetes Association (ADA) recommended targets associated with DKD in...

Descripción completa

Detalles Bibliográficos
Autores principales: Sekercioglu, Nigar, Lovblom, Leif Erik, Bjornstad, Petter, Lovshin, Julie A., Lytvyn, Yuliya, Boulet, Geneviève, Farooqi, Mohammed A., Orszag, Andrej, Lai, Vesta, Tse, Josephine, Cham, Leslie, Keenan, Hillary A., Brent, Michael H., Paul, Narinder, Bril, Vera, Perkins, Bruce A., Cherney, David Z. I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566893/
https://www.ncbi.nlm.nih.gov/pubmed/31162987
http://dx.doi.org/10.1080/0886022X.2019.1614057
_version_ 1783426951692681216
author Sekercioglu, Nigar
Lovblom, Leif Erik
Bjornstad, Petter
Lovshin, Julie A.
Lytvyn, Yuliya
Boulet, Geneviève
Farooqi, Mohammed A.
Orszag, Andrej
Lai, Vesta
Tse, Josephine
Cham, Leslie
Keenan, Hillary A.
Brent, Michael H.
Paul, Narinder
Bril, Vera
Perkins, Bruce A.
Cherney, David Z. I.
author_facet Sekercioglu, Nigar
Lovblom, Leif Erik
Bjornstad, Petter
Lovshin, Julie A.
Lytvyn, Yuliya
Boulet, Geneviève
Farooqi, Mohammed A.
Orszag, Andrej
Lai, Vesta
Tse, Josephine
Cham, Leslie
Keenan, Hillary A.
Brent, Michael H.
Paul, Narinder
Bril, Vera
Perkins, Bruce A.
Cherney, David Z. I.
author_sort Sekercioglu, Nigar
collection PubMed
description Objectives: Diabetic kidney disease (DKD) is an independent predictor of cardiovascular morbidity and mortality in type 1 diabetes (T1D). We aimed to explore clinical and biochemical factors, including the achievement of American Diabetes Association (ADA) recommended targets associated with DKD in people living with T1D for ≥50 years. Methods: This was a post hoc analysis of a cross-sectional study of 75 participants enrolled in the Canadian Study of Longevity in T1D. We explored diabetes-related complications, including neuropathy, retinopathy, cardiovascular disease, and DKD. Study participants were dichotomized based on the achievement of ADA recommended targets as the low-target group (achieving ≤4 targets, n = 31) and high-target group (achieving >4 targets, n = 44). The outcome of interest was DKD defined by estimated glomerular filtration rate (eGFR) values <60/mL/min/1.73 m(2) and/or 24-h albumin excretion >30 mg. Multivariable logistic regression models were employed to estimate odds ratios (ORs) for DKD with 95% confidence intervals (CIs). Results: Of the 75 participants with prolonged T1D duration (45% male, mean age 66 years), 25 participants had DKD and 50 did not. There was no statistical difference between the high- and low-target groups in terms of age and body mass index. eGFR was significantly higher and the prevalence of diabetic retinopathy was significantly lower in the high-target group. Older age at diagnosis of T1D and lower frequency component to high-frequency component ratio increased the odds of having DKD. Conclusions: In adults with prolonged T1D duration, older age at diagnosis and lower heart rate variability may be associated with DKD.
format Online
Article
Text
id pubmed-6566893
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-65668932019-06-21 Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes Sekercioglu, Nigar Lovblom, Leif Erik Bjornstad, Petter Lovshin, Julie A. Lytvyn, Yuliya Boulet, Geneviève Farooqi, Mohammed A. Orszag, Andrej Lai, Vesta Tse, Josephine Cham, Leslie Keenan, Hillary A. Brent, Michael H. Paul, Narinder Bril, Vera Perkins, Bruce A. Cherney, David Z. I. Ren Fail Clinical Study Objectives: Diabetic kidney disease (DKD) is an independent predictor of cardiovascular morbidity and mortality in type 1 diabetes (T1D). We aimed to explore clinical and biochemical factors, including the achievement of American Diabetes Association (ADA) recommended targets associated with DKD in people living with T1D for ≥50 years. Methods: This was a post hoc analysis of a cross-sectional study of 75 participants enrolled in the Canadian Study of Longevity in T1D. We explored diabetes-related complications, including neuropathy, retinopathy, cardiovascular disease, and DKD. Study participants were dichotomized based on the achievement of ADA recommended targets as the low-target group (achieving ≤4 targets, n = 31) and high-target group (achieving >4 targets, n = 44). The outcome of interest was DKD defined by estimated glomerular filtration rate (eGFR) values <60/mL/min/1.73 m(2) and/or 24-h albumin excretion >30 mg. Multivariable logistic regression models were employed to estimate odds ratios (ORs) for DKD with 95% confidence intervals (CIs). Results: Of the 75 participants with prolonged T1D duration (45% male, mean age 66 years), 25 participants had DKD and 50 did not. There was no statistical difference between the high- and low-target groups in terms of age and body mass index. eGFR was significantly higher and the prevalence of diabetic retinopathy was significantly lower in the high-target group. Older age at diagnosis of T1D and lower frequency component to high-frequency component ratio increased the odds of having DKD. Conclusions: In adults with prolonged T1D duration, older age at diagnosis and lower heart rate variability may be associated with DKD. Taylor & Francis 2019-06-04 /pmc/articles/PMC6566893/ /pubmed/31162987 http://dx.doi.org/10.1080/0886022X.2019.1614057 Text en © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Sekercioglu, Nigar
Lovblom, Leif Erik
Bjornstad, Petter
Lovshin, Julie A.
Lytvyn, Yuliya
Boulet, Geneviève
Farooqi, Mohammed A.
Orszag, Andrej
Lai, Vesta
Tse, Josephine
Cham, Leslie
Keenan, Hillary A.
Brent, Michael H.
Paul, Narinder
Bril, Vera
Perkins, Bruce A.
Cherney, David Z. I.
Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes
title Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes
title_full Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes
title_fullStr Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes
title_full_unstemmed Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes
title_short Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes
title_sort risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the canadian study of longevity in diabetes
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566893/
https://www.ncbi.nlm.nih.gov/pubmed/31162987
http://dx.doi.org/10.1080/0886022X.2019.1614057
work_keys_str_mv AT sekercioglunigar riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes
AT lovblomleiferik riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes
AT bjornstadpetter riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes
AT lovshinjuliea riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes
AT lytvynyuliya riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes
AT bouletgenevieve riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes
AT farooqimohammeda riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes
AT orszagandrej riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes
AT laivesta riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes
AT tsejosephine riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes
AT chamleslie riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes
AT keenanhillarya riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes
AT brentmichaelh riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes
AT paulnarinder riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes
AT brilvera riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes
AT perkinsbrucea riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes
AT cherneydavidzi riskfactorsfordiabetickidneydiseaseinadultswithlongstandingtype1diabetesresultsfromthecanadianstudyoflongevityindiabetes